Autophagy Inhibition in Pancreatic Adenocarcinoma

Brian A. Boone, Herbert J. Zeh, Nathan Bahary

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Although some progress has been made in recent years with the development of more effective chemotherapy regimens, new treatment approaches are needed to improve outcomes for patients with pancreatic adenocarcinoma. The cellular process of autophagy, a cell survival mechanism that allows cancer cells to survive the hazardous conditions of the tumor microenvironment and treatment, has emerged as a viable target in pancreatic cancer. We review the mechanism of autophagy, its role in pancreatic carcinogenesis, the preclinical and clinical evidence supporting targeting autophagy in patients with pancreatic adenocarcinoma, and areas of future investigation that hold promise for improving this treatment approach.

Original languageEnglish (US)
Pages (from-to)25-31
Number of pages7
JournalClinical colorectal cancer
Issue number1
StatePublished - Mar 2018
Externally publishedYes


  • Apoptosis
  • Chloroquine
  • Damage-associated molecular pattern molecule (DAMP)
  • High-mobility group box 1 (HMGB1)
  • Hydroxychloroquine

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology


Dive into the research topics of 'Autophagy Inhibition in Pancreatic Adenocarcinoma'. Together they form a unique fingerprint.

Cite this